Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business Update

Pacira Pharma (PCRX) Tops Q3 EPS by 7c, Revenues Beat

October 29, 2020 8:07 AM EDT

Pacira Pharma (NASDAQ: PCRX) reported Q3 EPS of $0.68, $0.07 better than the analyst estimate of $0.61. Revenue for the quarter came in at $117.5 million versus the consensus estimate of $115.15 million.

Third Quarter 2020 Financial Results

Total revenues were $117.5 million in the third quarter of 2020, a 12% increase versus the $104.7 million reported for the third quarter of 2019.EXPAREL net product sales were $113.7 million in the third quarter of 2020, a 12% increase versus the $101.5 million reported for the third quarter of 2019.Third quarter 2020 iovera° net product sales were $2.7 million, a 3% increase versus the $2.6 million reported for the... More